Lv1
56 积分 2023-01-13 加入
FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer
5天前
已完结
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer
5天前
已完结
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial
10天前
已完结
Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
13天前
已完结
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance
17天前
已完结
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer
23天前
已完结
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder
23天前
已完结
Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management
1个月前
已完结
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer
1个月前
已完结
Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer
1个月前
已完结
皖公网安备34019202002308
